EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics 2026
The EORTC-NCI-AACR Symposium is a scientific meeting on molecular targets and cancer drug development, run by three cancer research organizations. It draws researchers, clinicians and industry experts working in drug development and translational research.
Wednesday to Friday · 3 days
CCIB
EORTC, NCI and AACR
Organizer
Published by the organizer
Checked November 1, 2026
About EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics 2026
The EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, known as ENA, is a scientific meeting on early cancer drug development. It's run jointly by EORTC, the US National Cancer Institute and the American Association for Cancer Research. The 38th edition runs 18 to 20 November 2026 at the CCIB in Barcelona. The organizers expect 1,500+ delegates, from researchers and clinicians to industry experts. The last Barcelona edition, in 2024, drew over 1,200 participants from 41 countries.
41
Countries represented
450+
Abstracts presented
60+
International speakers
30+
Hours of educational sessions
1,500+
Delegates (expected)
What happens at ENA 2026
ENA 2026 is a three-day program of plenaries, workshops, proffered papers and posters. The organizers say it spotlights preclinical and phase I studies on emerging targets and new drugs.
The program at a glance opens on Wednesday 18 November with a clinical trial methodology workshop. A keynote lecture and the first plenary on immune engagers follow in the afternoon.
Plenary themes include the RAS pathway, antibody drug conjugates and next-generation cell therapies. Workshops cover GLP-1 and cancer, radiopharmaceuticals, AI in early clinical development and proximity inducers. The Michel Clavel Lecture runs on Friday 20 November.
Late-breaking abstracts get their own slots across three plenary sessions. An AACR town hall on PRMT5 inhibitors runs at lunchtime on Thursday. A networking reception and poster viewing close the first day in the exhibition hall.
Registered delegates get access to session recordings for three months after the meeting. ENA 2026 has applied for European CME accreditation through EACCME.
Who attends ENA
ENA draws drug development scientists, oncologists and industry researchers. The organizers describe a global community of researchers, clinicians, and industry experts. The prospectus adds policymakers to that mix.
The latest published figures come from the 2024 Barcelona edition. The prospectus's look back at ENA 2024 lists 1,230 participants from 41 countries, 450+ abstracts and 60+ international speakers.
Scientists were by far the largest group in 2024, according to the same prospectus chart. Medical oncologists, translational scientists, business and financial analysts and students followed. Chemists, clinical oncologists, industry, pharmacologists and media made up the rest of the top 10.
The USA sent the most participants in 2024. The United Kingdom, Spain, China and France came next, followed by the Netherlands, South Korea, Switzerland, Japan and Germany. The prospectus doesn't print the counts behind these charts.
For 2026, the organizers expect to welcome 1,500+ delegates. That's a forecast, not a result.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance |
|---|---|
| 2024 | 1,230participants from 41 countriesFigure for the 2024 Barcelona edition, from the 2026 sponsorship prospectus. EORTC reported over 1,200 participants.event.eortc.org ↗ |
Companies exhibiting and presenting at ENA 2026
Contract research organizations and preclinical service firms make up most of the 2026 exhibitors. Pfizer and Revolution Medicines are the drug developers with booths on the official exhibition floor plan.
Exhibitors (15)Foundation Medicine, Reaction Biology, Xentech and 12 more
- Foundation Medicine · 2026Booth 1 on the official floor plan
- Reaction Biology · 2026Booth 2 on the official floor plan
- Xentech · 2026Booth 3 on the official floor plan
- WuXi AppTec · 2026Booth 5 on the official floor plan
- ICE Bioscience · 2026Booth 6 on the official floor plan
- FUJIFILM Wako Pure Chemical Corporation · 2026Booth 8 on the official floor plan
- Biocytogen · 2026Booth 9 on the official floor plan
- Champions Oncology · 2026Booth 10 on the official floor plan
- Pfizer · 2026Booth 11 on the official floor plan
- ChemPartner · 2026Booth 12 on the official floor plan
- Crown Bioscience · 2026Booth 13 on the official floor plan
- Turbine · 2026Booth 14 on the official floor plan
- Revolution Medicines · 2026Booth 15 on the official floor plan
- Kyinno · 2026Booth 16 on the official floor plan
- Studylog Systems · 2026Booth 17 on the official floor plan
Speakers' companies (10)Adlai Nortye, Erasca, Acrivon Therapeutics and 7 more
- Adlai Nortye · 2026Oral presentation on AN4035 by its president Archie Tse
- Erasca · 2026Oral presentation on ERAS-0015 and a combination poster
- Acrivon Therapeutics · 2026Late-breaking oral plenary on ACR-2316
- Purple Biotech · 2026Plenary oral presentation on IM1240
- Remix Therapeutics · 2026Late-breaking oral presentation on REM-422
- Pyxis Oncology · 2026Late-breaking oral presentation and two posters on micvotabart pelidotin
- Aprea Therapeutics · 2026Oral presentation on APR-1051
- Perspective Therapeutics · 2026Poster on VMT-alpha-NET
- Zymeworks · 2026Industry advisory committee member, chairs the ADC plenary
- Novartis · 2026Industry advisory committee member, chairs the proximity inducers workshop
Attending (4)Johnson and Johnson, AstraZeneca, Amgen and 1 more
Biotech companies have announced presentations of their own clinical and preclinical data. Big pharma groups also help shape the program through the industry advisory committee.
Every company below is confirmed for the 2026 edition by the organizer's pages or its own announcement.
Exhibitors at ENA 2026
ENA 2026 has a single exhibition hall shared with posters, coffee and lunch. The exhibitor manual places the exhibition in Halls 5 to 8 of the CCIB.
Our count of the official floor plan on 1 November 2026 found 17 named booths. Fifteen belong to companies, and AACR and EORTC hold the other two. The organizers don't publish a total exhibitor figure.
Stands are sold in 9 square meter units. The prospectus prices an industry shell scheme stand at 6,500 EUR. A newcomer stand costs 5,500 EUR and a medical societies stand 3,500 EUR. Space only costs 600 EUR per square meter.
The newcomer rate covers companies new to ENA in five years or start-ups with up to 80 staff. All rates exclude VAT. Extra exhibitor badges cost 105 EUR each.
Companies book by emailing the booking form to the secretariat. Space is allocated first come, first served, until eight weeks before the meeting. Exhibitors can rent lead retrieval scanners from COVR, the official scanner partner named in the manual. Compare options in our guide to lead retrieval apps.
Sponsors and partners at ENA 2026
ENA 2026 sells three partner tiers, and the organizers haven't published a sponsor list. The prospectus offers one exclusive Platinum package at 80,000 EUR, with a 27 square meter booth and a meeting room.
Gold costs 55,000 EUR and Silver 40,000 EUR. Both include a booth, delegate mailings and a four-sided tower. Smaller items include networking breaks, water bottles, a charging station and meeting room rental.
Sponsors can also fund resident and young scientist travel grants. The industry page holds the prospectus, order forms and a social media kit for sponsors. Teams planning sponsor packages can compare event sponsorship software.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
ENA 2026 attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Not published
Attendee list
Not published or sold
ENA doesn't publish or sell an attendee list. The prospectus says GDPR rules mean it can't provide delegate lists. Exhibitors can order a badge scanner instead.
The closest thing to an exhibitor list is the interactive exhibition floor plan. It names each booth holder and its booth number. No sponsor list was published when we checked.
The press office applies the same rule to journalists. Its media page says past and current media lists aren't given, rented or sold.
Our guide to how to find who's attending an event covers other routes. It also compares event intelligence platforms that track exhibitors and speakers.
See who's attending EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at ENA 2026
ENA 2026 has published its full speaker lineup in the searchable program. Tony S.K. Mok gives the keynote lecture, The rise of biotech in APAC, on Wednesday 18 November.
- Tony S.K. MokKeynote · Keynote Lecture. The rise of biotech in APAC · 2026
- Ugur SahinKeynote · Michel Clavel Lecture. Immunotherapy innovations · 2026
More speakers (42)Elena Garralda, Tim Greten, Ryan Corcoran and 39 more
- Elena GarraldaChair, ENA 2026, Vall d'Hebron Institute of OncologyWelcome to the ENA 2026 Symposium · 2026
- Tim GretenCo-chair, ENA 2026, National Cancer InstituteModerator · Michel Clavel Lecture (chair) · 2026
- Ryan CorcoranCo-chair, ENA 2026, Massachusetts General HospitalPlenary Session 2. Targeting RAS · 2026
- Timothy A. YapProfessor of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer CenterLate-breaking abstract on ACR-2316 · 2026
- Archie TsePresident and Head of R&D, Adlai NortyeLate-breaking abstract on AN4035 · 2026
- Alan HoChief of the Head and Neck Oncology Service, Memorial Sloan Kettering Cancer CenterLate-breaking abstract on REM-422 · 2026
- Faye JohnsonThe University of Texas MD Anderson Cancer CenterLate-breaking abstract on micvotabart pelidotin · 2026
- Amir HorowitzAssociate Professor, Icahn School of Medicine at Mount SinaiProffered paper on a tri-specific antibody · 2026
- Judy WangSarah Cannon Research InstituteProffered paper on ERAS-0015 · 2026
- Raffaele ColomboZymeworksPlenary Session 4. Antibody targeted therapy conjugates · 2026
- Shiva MalekNovartisWorkshop 8. Proximity inducers beyond current PROTACs · 2026
- Samra TurajlicPlenary Session 1. Tumor evolution and immune escape under therapy · 2026
- Paul ParrenPlenary Session 1. Rewiring T cell engagement · 2026
- Victor MorenoPlenary Session 1. Next generation multispecific immune engagers · 2026
- Aditya BardiaPlenary Session 4. Advancing bispecific antibody drug conjugates · 2026
- Piro LitoPlenary Session 2. Targeting RAS · 2026
- Chiara AmbrogioPlenary Session 2. Modeling resistance to KRAS inhibitors · 2026
- Mariano BarbacidPlenary Session 2. Triplet combination therapy in PDAC models · 2026
- Paolo TarantinoPlenary Session 4. Antibody drug conjugates · 2026
- Nicole BiberPlenary Session 4. Degrader antibody conjugates · 2026
- Elham AdabiPlenary Session 5. In vivo CAR-T · 2026
- Alena GrosPlenary Session 5. Neoantigen TCR-T · 2026
- Marco DoniaPlenary Session 5. Cell therapy platforms · 2026
- Zachary SteinhartPlenary Session 5. CRISPR screens in CAR T cells · 2026
- Lillian L. SiuWorkshop 7. ctDNA · 2026
- Ruth PlummerWorkshop 4. Targeting DDR · 2026
- Sophie Postel-VinayWorkshop 4. MTA-cooperative PRMT5 inhibitors · 2026
- Jordi RodonAACR CICR town hall. Clinical trials with PRMT5 inhibitors · 2026
- Caroline ChungWorkshop 3. Digital twins and multiomics · 2026
- Jorge S. Reis-FilhoWorkshop 3. Multimodal foundation models · 2026
- Dmitry GabrilovichWorkshop 6. Myeloid cells in tumor progression · 2026
- Udai BanerjiWorkshop 6. Targeting fibroblast activation protein · 2026
- Nicolas ThomäWorkshop 8. Targeted protein degradation · 2026
- Victoria Bae-JumpWorkshop 1. GLP1-RAs in endometrial cancer · 2026
- Caroline StokkeWorkshop 2. Designing radioligand trials · 2026
- Patrick FordeProffered paper on BNT116 · 2026
- Patrick SchöffskiLate-breaking abstract on an ADC in soft tissue sarcoma · 2026
- David S. HongLate-breaking abstract on ALTA3263 · 2026
- Alison SchramLate-breaking abstract on rezatapopt · 2026
- Ecaterina DumbravaLate-breaking abstract on NTS071 · 2026
- Laura SoucekProffered paper on OMO-103 · 2026
- Saskia LitièreClinical Trial Methodology Workshop · 2026
Ugur Sahin gives the Michel Clavel Lecture on immunotherapy innovations on Friday 20 November. The scientific chairs are Elena Garralda of the Vall d'Hebron Institute of Oncology, Tim Greten of the NCI and Ryan Corcoran of Massachusetts General Hospital.
Plenary speakers include Samra Turajlic, Mariano Barbacid, Piro Lito, Aditya Bardia, Paolo Tarantino and Lillian Siu. Timothy Yap of MD Anderson presents four abstracts and chairs a workshop.
Many proffered paper talks come with company releases. Alan Ho of Memorial Sloan Kettering presents REM-422 results for Remix. Judy Wang of Sarah Cannon Research Institute presents Erasca's ERAS-0015 data.
The program covers drug design, combination therapies, immuno-oncology, AI, drug resistance and novel trial design, among the listed abstract topics. Abstract submission closed on 8 July 2026. Late-breaking abstracts were taken from 12 to 19 October 2026.
Dates, venue and getting there
ENA 2026 runs from Wednesday 18 to Friday 20 November 2026. It's held at the Centre de Convencions Internacional de Barcelona on Plaça de Willy Brandt. The CCIB's own site lists 100,000 square meters of total floor area.
Opening hours are 11 a.m. to 7 p.m. on 18 November and 9 a.m. to 7 p.m. on 19 November. The final day runs 8 a.m. to 4.30 p.m.
The Lufthansa Group offers up to 10% off flights to Barcelona for travel between 11 and 27 November 2026. BCO Congresos is the official hotel partner.
Tickets and registration
Registration is open to academics, industry staff and students in training. The registration page lists late rates, valid until 4 November 2026, of 1,015 EUR for academics and 1,715 EUR for industry.
Students and residents in training pay 465 EUR. From 5 November, onsite rates rise to 1,240 EUR, 2,040 EUR and 595 EUR. Fees include 10% Spanish VAT. We checked these prices in November 2026.
A day rate of 690 EUR is sold only onsite. Registration covers the opening ceremony, the networking reception, the exhibition, coffee and lunch, and three months of webcasts.
Accredited journalists can register for free. Staff from pharmaceutical companies, PR agencies and financial analysts register as regular participants.
History of the EORTC-NCI-AACR Symposium
ENA 2026 is the 38th symposium in the series. The 36th edition ran at the CCIB in Barcelona in October 2024. EORTC said it had a record number of abstract submissions since 2012.
EORTC's CEO said the 2025 edition would take place in the USA, led by AACR. The Barcelona edition returns in 2026, chaired by Elena Garralda.
AACR also runs its own large meeting, the AACR Annual Meeting. Oncology teams often plan ENA alongside ESMO Congress, which also meets in Barcelona.
Resources for exhibitors, sponsors and attendees
These official pages cover registration, exhibiting and the scientific program.
- ENA 2026 home pageWith dates, key numbers and the chairs.
- Registration and feesFor academic, industry and student passes.
- Searchable programWith every session and speaker.
- Program at a glance (PDF)For a one-page view of each day.
- Sponsorship and exhibition prospectus (PDF)With stand and partner prices.
- Exhibitor manual (PDF)With build-up times, rules and the scanner partner.
- Industry pageWith the booking form, order forms and floor plan.
- General informationOn the venue, opening hours and cancellations.
- Media registration and embargo policyFor journalists.
- Travel grantsFor residents in training and young scientists.